<<

COVER ARTICLE PROBLEM-ORIENTED DIAGNOSIS

Jaundice in the Adult Patient SEAN P. ROCHE, M.D., Albany Medical College, Albany, New York REBECCA KOBOS, M.D., University of Nevada School of Medicine, Reno, Nevada

Jaundice in an adult patient can be caused by a wide variety of benign or life-threat- ening disorders. Organizing the differential diagnosis by prehepatic, intrahepatic, and posthepatic causes may help make the work-up more manageable. Prehepatic causes of jaundice include and hematoma resorption, which lead to elevated levels of unconjugated (indirect) . Intrahepatic disorders can lead to unconjugated or conjugated hyperbilirubinemia. The conjugated (direct) bilirubin level is often elevated by alcohol, infectious , drug reactions, and autoimmune disorders. Posthep- atic disorders also can cause conjugated hyperbilirubinemia. formation is the most common and benign posthepatic process that causes jaundice; however, the dif- ferential diagnosis also includes serious conditions such as infection, pan- creatitis, and malignancies. The laboratory work-up should begin with a test for bilirubin, which indicates that conjugated hyperbilirubinemia is present. If the com- plete blood count and initial tests for function and infectious hepatitis are unre- vealing, the work-up typically proceeds to abdominal imaging by ultrasonography or computed tomographic scanning. In a few instances, more invasive procedures such as cholangiography or liver biopsy may be needed to arrive at a diagnosis. (Am Fam Physician 2004;69:299-304. Copyright© 2004 American Academy of Family Physicians.)

he word “jaundice” comes intrahepatic, and posthepatic. Dysfunc- from the French word jaune, tion in any of these phases may lead to which means yellow. Jaun- jaundice. dice is a yellowish staining of the skin, sclera, and mucous PREHEPATIC PHASE membranesT by bilirubin, a yellow-orange The human body produces about 4 mg pigment. Bilirubin is formed by a per kg of bilirubin per day from the breakdown product of rings, usu- of heme. Approximately 80 ally from metabolized red blood cells. The percent of the heme moiety comes from discoloration typically is detected clini- catabolism of red blood cells, with the cally once the bilirubin level rises remaining 20 percent resulting from inef- above 3 mg per dL (51.3 µmol per L). fective erythropoiesis and breakdown of Jaundice is not a common presenting muscle and cytochromes. complaint in adults. When present, it Bilirubin is transported from the plasma may indicate a serious problem. This arti- to the liver for conjugation and excretion.1 cle discusses the evaluation of the adult patient with jaundice. A systematic INTRAHEPATIC PHASE Members of various approach is warranted to clarify the cause Unconjugated bilirubin is insoluble in family practice depart- quickly so that treatment can begin as water but soluble in fats. Therefore, it can ments develop articles soon as possible. easily cross the blood-brain barrier or enter for “Problem-Oriented Diagnosis.” This is one the placenta. In the hepatocyte, the uncon- in a series from the jugated bilirubin is conjugated with a sugar Department of Family The classic definition of jaundice is a via the and Community Medi- serum bilirubin level greater than 2.5 to and is then soluble in the aqueous bile. cine at Albany Medical 3 mg per dL (42.8 to 51.3 µmol per L) in College. Guest coordi- POSTHEPATIC PHASE nators of the series are conjunction with a clinical picture of yel- Neil C. Mitnick, D.O., low skin and sclera. Bilirubin metabolism Once soluble in bile, bilirubin is trans- and Mary F. Smith, Ph.D. takes place in three phases—prehepatic, ported through the biliary and cystic

Downloaded from the American Family Physician Web site at www.aafp.org/afp. Copyright© 2004 American Academy of Family Physicians. For the private, noncommercial use of one individual user of the Web site. All other rights reserved. TABLE 1 Intrahepatic Causes of Conjugated Hyperbilirubinemia

Hepatocellular disease Viral infections (, B, and C) Chronic alcohol use Autoimmune disorders ducts to enter the , where it is Drugs stored, or it passes through Vater’s ampulla to enter the duodenum. Inside the intestines, Parenteral nutrition some bilirubin is excreted in the stool, while the rest is metabolized by the gut flora into Dubin-Johnson syndrome and then reabsorbed. The Rotor’s syndrome majority of the urobilinogens are filtered from Primary biliary the blood by the kidney and excreted in the Primary sclerosing cholangitis urine. A small percentage of the urobilinogens are reabsorbed in the intestines and re- Adapted with permission from Pasha TM, Lindor KD. Diagnosis and therapy of cholestatic . excreted into the bile. Med Clin North Am 1996;80:996. Clinical Presentation of Jaundice Patients with jaundice may present with no symptoms at all (i.e., the condition is found accidentally), or they may present with a life- rots). Unlike true jaundice, carotenemia does threatening condition. The wide range of pos- not result in scleral icterus or elevation of the sibilities is based on the variety of underlying bilirubin level.8 causes and whether disease onset is quick or slow moving. PREHEPATIC CAUSES Patients presenting with acute illness, which Unconjugated hyperbilirubinemia results is frequently caused by infection, may seek from a derailment of the necessary bilirubin medical care because of fever, chills, abdomi- conjugation in the hepatocyte. This problem nal pain, and flu-like symptoms. For these may occur before bilirubin has entered the patients, the change in skin color may not be hepatocyte or within the liver cell. Excessive their greatest concern. heme metabolism, from hemolysis or reab- Patients with noninfectious jaundice may sorption of a large hematoma, results in signif- complain of weight loss or pruritus. Abdomi- icant increases in bilirubin, which may over- nal pain is the most common presenting whelm the conjugation process and lead to a symptom in patients with pancreatic or biliary state of unconjugated hyperbilirubinemia.10 tract cancers.2 Even something as nonspecific Hemolytic anemias usually result in mild as depression may be a presenting complaint bilirubin elevation, to about 5 mg per dL in patients with chronic infectious hepatitis (85.5 µmol per L), with or without clinical and in those with a history of alcoholism.3,4 jaundice. Hemolytic anemias result from Occasionally, patients may present with abnormal survival times. These jaundice and some extrahepatic manifesta- anemias may occur because of membrane tions of liver disease. Examples include abnormalities (e.g., ) patients with chronic hepatitis and pyoderma or enzyme abnormalities (e.g., glucose-6- gangrenosum, and patients with acute hepati- phosphate dehydrogenase deficiency). Other tis B or C and polyarthralgias.5-7 etiologies of hemolysis include autoimmune disorders, drugs, and defects in Differential Diagnosis structure such as and the Jaundice can be caused by a malfunction in thalassemias.11 any of the three phases of bilirubin produc- tion (Tables 1 and 2).8 Pseudojaundice can INTRAHEPATIC CAUSES occur with excessive ingestion of foods rich in Unconjugated Hyperbilirubinemia. Several beta-carotene (e.g., squash, melons, and car- disorders of enzyme metabolism affect the

300 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 69, NUMBER 2 / JANUARY 15, 2004 Jaundice TABLE 2 Extrahepatic Causes of Conjugated Hyperbilirubinemia

Intrinsic to the ductal system Surgical strictures Infection (cytomegalovirus, Cryptosporidium infection in patients with acquired immunodeficiency syndrome) The mild hyperbilirubinemia of Gilbert syndrome typically is Intrahepatic malignancy found incidentally on routine liver function testing but may Extrinsic to the ductal system progress to jaundice during periods of stress, fasting, or illness. Extrahepatic malignancy (, lymphoma) Pancreatitis Hepatitis B and C infections often do not Adapted with permission from Pasha TM, Lindor KD. cause jaundice during the initial phases but Diagnosis and therapy of cholestatic liver disease. Med Clin North Am 1996;80:996. can lead to progressive jaundice when chronic infection has progressed to liver cirrhosis. Epstein-Barr virus infection (infectious mononucleosis) occasionally causes transient hepatitis and jaundice that resolve as the ill- conjugation process inside the hepatocyte, ness clears.1,8 thereby impeding complete conjugation. Alcohol has been shown to affect There are varying degrees of unconjugated uptake and secretion, resulting in . hyperbilirubinemia, depending on the sever- Chronic alcohol use may result in fatty liver ity of enzyme inhibition with each disease. (steatosis), hepatitis, and cirrhosis, with vary- Gilbert syndrome is a common, benign, ing levels of jaundice. Fatty liver, the most hereditary disorder that affects approximately common pathologic liver finding, usually 5 percent of the U.S. population.1 Typically, results in mild symptoms without jaundice the disease results in a mild decrease in the but occasionally progresses to cirrhosis. activity of the enzyme glucuronosyltrans- Hepatitis secondary to alcohol use typically ferase, causing an increase in the indirect frac- presents with acute onset of jaundice and tion of serum bilirubin. Gilbert syndrome is more severe symptoms. Liver cell necrosis is typically an incidental finding on routine liver indicated by highly elevated serum , when the bilirubin level is levels.12 slightly increased and all other liver function Autoimmune hepatitis traditionally has values are within normal limits. Jaundice and been considered a disease that affects younger further elevation of the bilirubin level may persons, especially women. Recent data, how- occur during periods of stress, fasting, or ill- ever, support the consideration of this diagno- ness. However, these changes are usually tran- sis in older patients who present with acute sient, and there is no need to pursue treatment icteric hepatitis.13 Two serious autoimmune or liver biopsy.1 diseases that directly affect the biliary system Conjugated Hyperbilirubinemia. The pre- without causing much hepatitis are primary dominant causes of conjugated hyperbiliru- biliary cirrhosis and primary sclerosing binemia are intrahepatic cholestasis and cholangitis. Primary biliary cirrhosis is a rare extrahepatic obstruction of the biliary tract, progressive liver disease that typically presents with the latter preventing bilirubin from mov- in middle-aged women. Fatigue and pruritus ing into the intestines. are common initial complaints, while jaun- Viruses, alcohol, and autoimmune disor- dice is a later finding. Primary sclerosing ders are the most common causes of hepatitis. cholangitis, another rare cholestatic entity, is Intrahepatic inflammation disrupts transport more common in men; nearly 70 percent of of conjugated bilirubin and causes jaundice. patients also have inflammatory bowel dis- Hepatitis A is usually a self-limited illness ease. Primary sclerosing cholangitis may lead that presents with acute onset of jaundice. to cholangiocarcinoma.8

JANUARY 15, 2004 / VOLUME 69, NUMBER 2 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 301 cholangitis or infection. Cholangitis is diag- Posthepatic causes of jaundice range from relatively benign nosed clinically by the classic symptoms of gallstones to life-threatening malignancies. fever, pain, and jaundice, known as Charcot’s triad. Cholangitis most commonly occurs because of an impacted gallstone.16 Impacted gallstones typically require chole- Dubin-Johnson syndrome and Rotor’s syn- cystectomy or endoscopic removal, depending drome are rare hereditary metabolic defects on the stone location. Biliary strictures and that disrupt transport of conjugated bilirubin infection should be considered in patients from the hepatocyte.8 with postoperative jaundice.10,16 Many drugs have been shown to play a role Biliary tract tumors are uncommon but in the development of cholestatic jaundice. serious causes of posthepatic jaundice. Gall- Agents classically identified with drug- bladder cancer classically presents with jaun- induced liver disease are acetaminophen, dice, hepatomegaly, and a mass in the right penicillins, oral contraceptives, chlorpro- upper quadrant (Courvoisier’s sign). Survival mazine (Thorazine), and estrogenic or ana- rates, based on tumor stage, range from 2 to bolic steroids. Cholestasis can develop during 85 percent. Another biliary system cancer, the first few months of oral contraceptive use cholangiocarcinoma, typically manifests as and may result in jaundice.14 jaundice, pruritus, weight loss, and . It accounts for roughly 25 percent of POSTHEPATIC CAUSES hepatobiliary cancers and is associated with Conjugated hyperbilirubinemia also may an approximately 50 percent survival rate.16 result from problems that occur after the Jaundice also may arise secondary to pan- bilirubin is conjugated in the liver. These post- creatitis. The most common causes of pancre- hepatic causes can be divided into intrinsic or atitis are gallstones and alcohol use. Gallstones extrinsic obstruction of the duct system are responsible for more than one half of cases (Table 2).8 of acute pancreatitis, which is caused by Cholelithiasis, or the presence of gallstones obstruction of the common duct that drains in the gallbladder, is a relatively common find- the biliary and pancreatic systems.15 Even ing in adult patients, with or without symp- without duct obstruction from a stone, pan- toms of obstruction.15 Obstruction within the creatitis can lead to secondary com- biliary duct system may lead to , pression from pancreatic edema.12 or inflammation of the gallbladder, as well as Physical Examination The physical examination should focus pri- marily on signs of liver disease other than The Authors jaundice, including bruising, spider angiomas, SEAN P. ROCHE, M.D., is assistant professor of family and community medicine at Albany gynecomastia, testicular atrophy, and palmar (N.Y.) Medical College and associate director of the family practice residency program at Albany Medical Center. Dr. Roche received his medical degree from the State University erythema. An abdominal examination to of New York (SUNY) Upstate Medical University, Syracuse. He completed a family medi- assess liver size and tenderness is important. cine residency and served as chief resident at Albany Medical Center. The presence or absence of ascites also should REBECCA KOBOS, M.D., is assistant professor of family and community medicine at be noted. the University of Nevada School of Medicine, Reno. Dr. Kobos received her medical degree from SUNY Upstate Medical University. She completed a family medicine resi- Evaluation dency at Albany Medical Center, where she served as chief resident. The initial work-up of the patient with Address correspondence to Sean P. Roche, M.D., Department of Family and Commu- nity Medicine, Albany Medical College, 2 Clara Barton Dr., Albany, NY 12208. Reprints jaundice depends on whether the hyperbiliru- are not available from the authors. binemia is conjugated (direct) or unconju-

302 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 69, NUMBER 2 / JANUARY 15, 2004 Jaundice

Clinical Jaundice in Adults

Check urinalysis; measure serum total and direct bilirubin levels. gated (indirect). A urinalysis that is positive for bilirubin indicates the presence of conjugated bilirubinemia. Conjugated bilirubin is water All tests normal Urine positive for bilirubin; Urine negative for soluble and therefore able to be excreted in increased total bilirubin bilirubin; increased urine. The findings of urinalysis should be level and increased total bilirubin level Look for direct bilirubin level and normal direct confirmed by measurements of the serum “pseudojaundice.” bilirubin level total and direct bilirubin levels (Figure 1). Conjugated SERUM TESTING High vegetable hyperbilirubinemia Unconjugated First-line serum testing in a patient present- intake hyperbilirubinemia ing with jaundice should include a complete Liver function tests (AST, blood count (CBC) and determination of ALT, AP, GGT, and CBC) Hemolysis, drug toxicity, bilirubin (total and direct fractions), aspartate genetic syndrome transaminase (AST), (Gilbert syndrome), (ALT), -glutamyl transpeptidase, and alka- No diagnosis apparent? hematoma line phosphatase levels. A CBC is useful in detecting hemolysis, Screen for hepatitis which is indicated by the presence of fractured A, B, and C. red blood cells (schistocytes) and increased reticulocytes on the smear. AST and ALT are markers of hepatocellular No diagnosis apparent? injury. They can be less helpful in patients with chronic liver disease, because levels can be Screen for autoimmune normal or only slightly elevated when there is disorders (ANA, anti-LKM, little liver parenchyma left to damage. Acute anti-smooth muscle) viral hepatitis may cause the levels of ALT to rise several thousand units per liter. Levels greater than 10,000 U per L usually occur in If no obvious diagnosis, abdominal US or CT patients with acute injury to the liver from another source (e.g., drugs [acetaminophen] or ischemia).17 Patients with acute have Intrahepatic disease Extrahepatic disease AST and ALT levels that rise to several hun- (see Table 1) (see Table 2) dred units per liter. With alcohol-induced damage, the ratio of AST to ALT is usually greater than 1, whereas infectious causes of hepatitis typically cause greater elevation in Still no apparent diagnosis? ALT than in AST.18 and -glutamyltrans- Consider cholangiography ferase are markers for cholestasis. As bile or liver biopsy. obstruction progresses, the levels of these two markers rise several times above normal.17 Depending on the results of the initial tests, FIGURE 1. Algorithm for a systematic approach to the adult patient further serum tests or imaging studies may be with jaundice. (AST = ; ALT = alanine transami- nase; AP = alkaline phosphatase; GGT = -glutamyltransferase; CBC = warranted. The second-line serum investiga- ; ANA = antinuclear antibodies; anti-LKM = liver- tions may include tests for hepatitis A IgM kidney microsomal antibodies; US = ultrasonography; CT = computed antibody, hepatitis B surface antigen and core tomography)

JANUARY 15, 2004 / VOLUME 69, NUMBER 2 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 303 Jaundice

antibody, hepatitis C antibody, and autoim- The authors indicate that they do not have any con- mune markers such as antinuclear, smooth flicts of interests. Sources of funding: none reported.

muscle, and liver-kidney microsomal anti- REFERENCES bodies. An elevated level would cor- roborate the presence of pancreatitis when 1. Pashankar D, Schreiber RA. Jaundice in older chil- dren and adolescents. Pediatr Rev 2001;22:219-26. this condition is suspected based on the his- 2. Modolell I, Guarner L, Malagelada JR. Vagaries of tory or physical examination. clinical presentation of pancreatic and biliary tract cancer. Ann Oncol 1999;10(suppl 4):82-4. 3. Singh N, Gayowski T, Wagener MM, Marino IR. Vul- IMAGING nerability to psychologic distress and depression in Ultrasonography and computed tomo- patients with end-stage liver disease due to hepati- tis C virus. Clin Transplant 1997;11(5 pt 1):406-11. graphic (CT) scanning are useful in distin- 4. Ewusi-Mensah I, Saunders JB, Wodak AD, Murray guishing an obstructing lesion from hepatocel- RM, Williams R. Psychiatric morbidity in patients lular disease in the evaluation of a jaundiced with . Br Med J [Clin Res Ed] 1983;287:1417-9. patient. Ultrasonography is typically the first 5. Blitz NM, Rudikoff D. Pyoderma gangrenosum. Mt test ordered, because of its lower cost, wide Sinai J Med 2001;68:287-97. availability, and lack of radiation exposure, 6. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol 2000;12:295-9. which may be particularly important in preg- 7. Pyrsopoulos NT, Reddy K. Extrahepatic manifesta- nant patients. While ultrasonography is the tions of chronic viral hepatitis. Curr Gastroenterol most sensitive imaging technique for detecting Rep 2001;3:71-8. 8. Pasha TM, Lindor KD. Diagnosis and therapy of biliary stones, CT scanning can provide more cholestatic liver disease. Med Clin North Am 1996; information about liver and pancreatic 80:995-1019. parenchymal disease. Neither modality is good 9. Pinto F, Mognol D, Garbelotto G, Dannhauser D, 19 Grava G, Sanzuol F. Carotenodermia: an erroneous at delineating intraductal stones. diagnosis of jaundice [in Italian]. Recenti Prog Med Further imaging that may be done by a gas- 2000;91:70-1. troenterologist or interventional radiologist 10. Molina EG, Reddy KR. Postoperative jaundice. Clin Liver Dis 1999;3:477-88. includes endoscopic retrograde cholangio- 11. Sackey K. : part 1. Pediatr Rev pancreatography and percutaneous trans- 1999;20:152-8. hepatic cholangiography. 12. Tung BY, Carithers RL Jr. Cholestasis and alcoholic liver disease. Clin Liver Dis 1999;3:585-601. 13. Schramm C, Kanzler S, zum Buschenfelde KH, LIVER BIOPSY Galle PR, Lohse AW. Autoimmune hepatitis in the A liver biopsy provides information on the elderly. Am J Gastroenterol 2001;96:1587-91. 14. Lewis JH. Drug-induced liver disease. Med Clin architecture of the liver and is used mostly for North Am 2000;84:1275-311,x. determining prognosis. It also may be useful 15. Kalloo AN, Kantsevoy SV. Gallstones and biliary dis- for diagnosis if serum and imaging studies do ease. Prim Care 2001;28:591-606,vii. 16. Custis K. Common biliary tract disorders. Clin Fam not lead to a firm diagnosis. Liver biopsy can Pract 2000;2:141-54. be particularly helpful in diagnosing autoim- 17. Johnston DE. Special considerations in interpreting liver function tests. Am Fam Physician 1999;59: mune hepatitis or biliary tract disorders (e.g., 2223-30. primary biliary cirrhosis, primary sclerosing 18. Cohen JA, Kaplan MM. The SGOT/SGPT ratio—an cholangitis). Patients with primary biliary cir- indicator of alcoholic liver disease. Dig Dis Sci 1979;24:835-8. rhosis are almost always positive for antimito- 19. Pasanen PA, Partanen K, Pikkarainen P, Alhava E, chondrial antibody, and the majority of those Pirinen A, Janatuinen E. A prospective study on the affected by primary sclerosing cholangitis value of ultrasound, computed tomography and 8 endoscopic retrograde cholangiopancreatography have antineutrophil cytoplasmic antibodies. in the diagnosis of unjaundiced cholestasis. In Vivo The risk of fatal hemorrhage in patients 1994;8:227-30. undergoing percutaneous liver biopsy is 20. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21- year experience with major hemorrhage after per- 0.4 percent if they have a malignancy and 0.04 cutaneous liver biopsy. Gastroenterology 1990; percent if they have nonmalignant disease.20 99:1396-400.

304 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 69, NUMBER 2 / JANUARY 15, 2004